GlassScriptPhysician profile
Rajiv Sharma
NPI 1033372792
$6,142.98
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,929 · 2020: $1,164 · 2021: $656 · 2022: $420 · 2023: $484 · 2024: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017 · Travel and Lodging: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.22 |
| Travel and Lodging | $956.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,519.79 | 2019-2024 | Indigo System, Smart Coil |
| Bard Peripheral Vascular, INC. | $1,308.86 | 2019-2023 | |
| Cardiovascular Systems INC. | $455.57 | 2019 | |
| Bolton Medical INC | $416.06 | 2019 | |
| Boston Scientific Corporation | $399.21 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $271.16 | 2019-2023 | Eliquis |
| Abbott Laboratories | $256.20 | 2020-2021 | |
| Inari Medical, INC. | $157.65 | 2020 | |
| Medtronic, INC. | $128.50 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $49.48 | 2019-2023 | |
| Biocompatibles, INC. | $49.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.58 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.81 | 2019 | |
| W. L. Gore & Associates, INC. | $27.15 | 2021 | |
| Philips North America LLC | $24.96 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evoke Pharma, INC. | $21.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajiv Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.